Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo

Clinical trial NCT00133874 · COMPLETED

Trial details

NCT number: NCT00133874
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Skin Infections, Bacterial

Start date: 2005-04-01
Primary completion: 2005-09-01
Enrollment: 520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.